Biotech · Private company
Leidos Life Sciences
Track this companyFree. Adds Leidos Life Sciences to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CelecoxibPhase 2 · 2019 Novel Coronavirus DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- FamotidinePhase 2 · 2019 Novel Coronavirus DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sonocea Sonic Augmentation Technology (SAT)Long COVID SymptomsClinicalTrials.gov · fetched Nov 12, 2026
- Truvaga Electrical Vagus Nerve StimulatorLong COVID SymptomsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Vagal Approaches on Long COVID-19NA · COMPLETED · started Oct 27, 2025ClinicalTrials.gov NCT07190105 · fetched Nov 12, 2026
- LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)PHASE2 · COMPLETED · started Dec 29, 2021ClinicalTrials.gov NCT05077332 · fetched Nov 12, 2026
- Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 PatientsPHASE2 · TERMINATED · started Dec 29, 2021ClinicalTrials.gov NCT05077969 · fetched Nov 12, 2026